Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

Clinical Trial ID NCT04758481

Rank	Title	Journal	Year	PubWeight™‹?›
1	Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?	Int J Radiat Oncol Biol Phys	2010	3.66
2	Stereotactic body radiotherapy for oligometastatic lung tumors.	Int J Radiat Oncol Biol Phys	2008	2.11
3	Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.	J Thorac Oncol	2010	1.64
4	Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer.	Radiother Oncol	2011	1.48
5	MicroRNA expression characterizes oligometastasis(es).	PLoS One	2011	1.45
6	Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung.	Acta Oncol	2012	0.99
7	Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT).	Cancer	2016	0.93
8	Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.	Ann Oncol	2014	0.85
9	Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung.	J Thorac Dis	2014	0.82
10	The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.	Lung Cancer	2015	0.78